Imricor Medical Systems, Inc.
ASX:IMR.AX
0.78 (AUD) • At close October 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.204 | 0.204 | 0.208 | 0.208 | 0.1 | 0.1 | 0.139 | 0.139 | 0.269 | 0.269 | 0.165 | 0.165 | 0.183 | 0.183 | 0.212 | 0.212 | 0.139 | 0.139 | 0.293 | 0.293 | 0.027 | 0.027 | 0.158 | 0.158 | 0.343 | 0.343 |
| Cost of Revenue
| 0.474 | 0.474 | 0.395 | 0.395 | 0.471 | 0.471 | 0.474 | 0.474 | 0.698 | 0.698 | 0.722 | 0.722 | 0.574 | 0.574 | 0.366 | 0.366 | 0.184 | 0.184 | 0.189 | 0.189 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.27 | -0.27 | -0.187 | -0.187 | -0.371 | -0.371 | -0.335 | -0.335 | -0.429 | -0.429 | -0.557 | -0.557 | -0.391 | -0.391 | -0.154 | -0.154 | -0.045 | -0.045 | 0.104 | 0.104 | 0.027 | 0.027 | 0.158 | 0.158 | 0.343 | 0.343 |
| Gross Profit Ratio
| -1.325 | -1.325 | -0.896 | -0.896 | -3.731 | -3.731 | -2.408 | -2.408 | -1.593 | -1.593 | -3.376 | -3.376 | -2.135 | -2.135 | -0.725 | -0.725 | -0.323 | -0.323 | 0.355 | 0.355 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 1.899 | 1.899 | 2 | 2 | 1.96 | 1.96 | 1.742 | 1.742 | 2.231 | 2.231 | 2.501 | 2.501 | 2.337 | 2.337 | 1.556 | 1.556 | 1.217 | 1.217 | 0.916 | 0.916 | 0.884 | 0.884 | 0.889 | 0.889 | 0.874 | 0.874 |
| General & Administrative Expenses
| 1.278 | 1.278 | 1.141 | 1.141 | 1.403 | 1.403 | 1.041 | 1.041 | 1.45 | 1.45 | 1.469 | 1.469 | 1.441 | 1.441 | 1.096 | 1.096 | 1.068 | 1.068 | 0.791 | 0.791 | 0.527 | 0.527 | 0.402 | 0.402 | 0.393 | 0.393 |
| Selling & Marketing Expenses
| 0.584 | 0.584 | 0.54 | 0.54 | 0.826 | 0.826 | 0.658 | 0.658 | 0.744 | 0.744 | 0.727 | 0.727 | 0.707 | 0.707 | 0.49 | 0.49 | 0.351 | 0.351 | 0.162 | 0.162 | 0.125 | 0.125 | 0.165 | 0.165 | 0.187 | 0.187 |
| SG&A
| 1.861 | 1.861 | 1.68 | 1.68 | 2.229 | 2.229 | 1.699 | 1.699 | 2.195 | 2.195 | 2.196 | 2.196 | 2.148 | 2.148 | 1.587 | 1.587 | 1.419 | 1.419 | 0.953 | 0.953 | 0.651 | 0.651 | 0.567 | 0.567 | 0.58 | 0.58 |
| Other Expenses
| -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 3.761 | 3.761 | 3.68 | 6.524 | 4.239 | 4.239 | 3.445 | 3.445 | 4.434 | 4.434 | 4.342 | 4.342 | 4.531 | 4.531 | 3.113 | 3.113 | 2.775 | 2.775 | 4.018 | 4.018 | 2.251 | 2.251 | 1.408 | 1.408 | 1.425 | 1.425 |
| Operating Income
| -4.031 | -4.031 | -3.867 | -3.867 | -4.561 | -4.561 | -3.776 | -3.776 | -4.855 | -4.855 | -5.253 | -5.253 | -4.876 | -4.876 | -3.297 | -3.297 | -2.681 | -2.681 | -1.766 | -1.766 | -1.508 | -1.508 | -1.298 | -1.298 | -1.11 | -1.11 |
| Operating Income Ratio
| -19.77 | -19.77 | -18.566 | -18.566 | -45.834 | -45.834 | -27.156 | -27.156 | -18.048 | -18.048 | -31.835 | -31.835 | -26.63 | -26.63 | -15.53 | -15.53 | -19.319 | -19.319 | -6.035 | -6.035 | -55.298 | -55.296 | -8.217 | -8.217 | -3.235 | -3.235 |
| Total Other Income Expenses Net
| 0.602 | 0.602 | -2.836 | -2.836 | -0.049 | -0.049 | -0.015 | -0.015 | -0.033 | -0.033 | 0.368 | 0.368 | -0.105 | -0.105 | -0.027 | -0.027 | -0.218 | -0.218 | -2.356 | -2.356 | -1.017 | -1.017 | -0.175 | -0.175 | -0.141 | -0.141 |
| Income Before Tax
| -3.429 | -3.429 | -6.703 | -6.703 | -4.61 | -4.61 | -3.79 | -3.79 | -4.888 | -4.888 | -4.885 | -4.885 | -4.981 | -4.981 | -3.324 | -3.324 | -2.899 | -2.899 | -4.122 | -4.122 | -2.525 | -2.525 | -1.473 | -1.473 | -1.251 | -1.251 |
| Income Before Tax Ratio
| -16.819 | -16.819 | -32.183 | -32.183 | -46.329 | -46.329 | -27.263 | -27.263 | -18.172 | -18.172 | -29.603 | -29.603 | -27.203 | -27.203 | -15.658 | -15.658 | -20.89 | -20.89 | -14.088 | -14.088 | -92.59 | -92.587 | -9.324 | -9.324 | -3.645 | -3.645 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -3.429 | -3.429 | -6.703 | -6.703 | -4.61 | -4.61 | -3.79 | -3.79 | -4.888 | -4.888 | -4.885 | -4.885 | -4.981 | -4.981 | -3.324 | -3.324 | -2.899 | -2.899 | -4.122 | -4.122 | -2.525 | -2.525 | -1.473 | -1.473 | -1.251 | -1.251 |
| Net Income Ratio
| -16.819 | -16.819 | -32.183 | -32.183 | -46.329 | -46.329 | -27.263 | -27.263 | -18.172 | -18.172 | -29.603 | -29.603 | -27.203 | -27.203 | -15.658 | -15.658 | -20.89 | -20.89 | -14.088 | -14.088 | -92.59 | -92.587 | -9.324 | -9.324 | -3.645 | -3.645 |
| EPS
| -0.018 | -0.018 | -0.041 | -0.041 | -0.03 | -0.03 | -0.026 | -0.026 | -0.034 | -0.034 | -0.036 | -0.036 | -0.04 | -0.04 | -0.029 | -0.029 | -0.028 | -0.028 | -0.054 | -0.054 | -0.057 | -0.057 | -0.035 | -0.035 | -0.03 | -0.03 |
| EPS Diluted
| -0.018 | -0.018 | -0.041 | -0.041 | -0.03 | -0.03 | -0.026 | -0.026 | -0.034 | -0.034 | -0.036 | -0.036 | -0.04 | -0.04 | -0.029 | -0.029 | -0.028 | -0.028 | -0.054 | -0.054 | -0.057 | -0.057 | -0.035 | -0.035 | -0.03 | -0.03 |
| EBITDA
| -3.846 | -3.846 | -3.69 | -3.69 | -4.383 | -4.383 | -3.589 | -3.589 | -4.685 | -4.685 | -5.075 | -5.075 | -4.71 | -4.71 | -3.147 | -3.147 | -2.567 | -2.567 | -1.669 | -1.669 | -1.476 | -1.476 | -1.278 | -1.278 | -1.092 | -1.092 |
| EBITDA Ratio
| -18.864 | -18.864 | -17.719 | -17.719 | -44.052 | -44.052 | -25.815 | -25.815 | -17.417 | -17.417 | -30.753 | -30.753 | -25.724 | -25.723 | -14.824 | -14.824 | -18.497 | -18.497 | -5.704 | -5.704 | -54.129 | -54.127 | -8.087 | -8.087 | -3.182 | -3.182 |